(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






4 Result: DexCom

Momentum Builds: DexCom and Intel's Upbeat Results, Outlook

October 27th, 2023

DexCom, Inc. (Nasdaq: DXCM), a leading player in diabetes management technology, delivered an impressive performance in the third quarter of 2023, reporting adjusted earnings per share (EPS) of $0.50. This surpassed the consensus EPS estimate of $0.3. Read more

DexCom Gains Pre-Market Traction on Financial Figures, Bullish Views

July 28th, 2023

DexCom, Inc. (Nasdaq: DXCM) delivered strong results in the second quarter of 2023, with earnings per share (EPS) of $0.34 and revenues of $871.30 million, surpassing the consensus estimate of $0.23 EPS on revenue of $841.62 million. In response t. Read more

Health Canada OKs Dexcom G7; HC Wainwright Bullish on Ensysce, LifeMD, Genfit

July 04th, 2023

Dexcom, Inc. (Nasdaq: DXCM) received approval from Health Canada for the Dexcom G7 Continuous Glucose Monitoring System for all types of diabetes, ages two and older. This technology can help manage diabetes more effectively and has been shown to red. Read more

DexCom Boosts Outlook; Analysts Bullish on Chipotle, Clean Harbors, and Roivant

June 25th, 2023

DexCom, Inc. (Nasdaq: DXCM) is making significant strides in its financial performance, leading the company to update its year-end 2025 revenue targets. With strong performance in the first two years of the target period, DexCom now expects to achiev. Read more

Load More Content